Peter Scheurer
Corporate Officer/Principal at vasopharm GmbH
Network origin in Peter Scheurer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Peter Scheurer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Julius-Maximilians-Universität Würzburg | College/University | Undergraduate Degree Corporate Officer/Principal | |
| OCEAN WILSONS HOLDINGS LIMITED | Marine Shipping | Director/Board Member | |
| London Business School | College/University | Masters Business Admin | |
| HAML Consulting GmbH | Chief Investment Officer | ||
| Peterhouse College Cambridge | College/University | Graduate Degree | |
| Coller Capital Ltd. (Hong Kong) | Investment Managers | Corporate Officer/Principal | |
Hansa Capital GmbH
 Hansa Capital GmbH Financial ConglomeratesFinance Part of Hanseatic Asset Management LBG, Hansa Capital GmbH is a Swiss company that provides investment services. The company is based in Pfäffikon, Switzerland. | Financial Conglomerates | Chief Investment Officer | |
| Ocean Wilsons (Investments) Ltd. | Director/Board Member | ||
| WILSON SONS S.A. | Other Transportation | Director/Board Member | |
| 4SC AG | Biotechnology | Director/Board Member | |
| CHDI Foundation, Inc. | Chief Tech/Sci/R&D Officer | ||
Lundbeck Research USA, Inc.
 Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| PAION AG | Pharmaceuticals: Major | Director/Board Member | |
| The University of Edinburgh | College/University | Doctorate Degree | |
| Max Planck Institute of Biochemistry | College/University | Doctorate Degree | |
Wave Life Sciences USA, Inc.
 Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Electric Utilities | Corporate Officer/Principal | |
| Technische Universität München | College/University | Undergraduate Degree | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member | |
| BIOHAVEN LTD. | Pharmaceuticals: Major | Director/Board Member | |
| New Biohaven Pharmaceuticals, Inc. | Director/Board Member | ||
EveryONE Medicines, Inc.
 EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| LIMINAL BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
| LIFELINE SCIENTIFIC, INC | Medical Specialties | Director/Board Member | |
| University of St. Andrews | College/University | Doctorate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Future Capital
 Future Capital Investment ManagersFinance Future Capital (Future Capital) is an independent venture capital firm which was founded in 1999 as the initiative of the Hessen State Government and Hoechst AG (now Sanofi-Aventis Group). The firm is headquartered in Frankfurt, Germany. | Investment Managers | Chief Executive Officer | |
| Ludwig-Maximilians-Universität München | College/University | Masters Business Admin | |
CEVEC Pharmaceuticals GmbH
 CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Creathor Venture Management GmbH
 Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions. | Investment Managers | Private Equity Investor | |
Blueprint Genetics Oy
 Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Biotechnology | Director/Board Member | |
| Hannover Medical School | College/University | Doctorate Degree | |
Janssen-Cilag GmbH
 Janssen-Cilag GmbH Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen-Cilag GmbH is a German pharmaceutical company that focuses on innovative medical research and product development to create a future where disease is no longer a concern. The company is based in Neuss, Germany. The company's Janssen Trial Finder website is designed to inform patients and healthcare professionals about participating in a Janssen clinical trial and to search for clinical trials nearby. Janssen-Cilag was founded in 1959, and Iris Zemzoum has been the CEO of the company since 2012. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Heinrich-Heine-Universität Düsseldorf | College/University | Corporate Officer/Principal | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
3i Private Equity
 3i Private Equity Investment ManagersFinance 3i Private Equity is a private equity firm, founded in 1945. The firm is headquartered in London, United Kingdom with additional offices around the world. | Investment Managers | Private Equity Investor | |
| University of Bocconi | College/University | Undergraduate Degree | |
Hologic Ltd.
 Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Medical Specialties | Director/Board Member | |
Fort Rock Capital Ltd.
 Fort Rock Capital Ltd. Financial ConglomeratesFinance Fort Rock Capital Ltd. provides investment services. The company is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Medinet Midco I Ltd.
 Medinet Midco I Ltd. Medical/Nursing ServicesHealth Services Part of Medinet Topco Ltd., Medinet Midco I Ltd. is a provider of specialised clinical teams that deliver additional elective services to the NHS. The company is based in Sutton Coldfield, UK. Medinet Midco I offers urology and dermatology insourcing services, as well as fully managed specialised clinical teams. The British company was founded in 2016 and has been helping to reduce NHS waiting times for 15 years. | Medical/Nursing Services | Director/Board Member | |
Medinet Midco II Ltd.
 Medinet Midco II Ltd. Financial ConglomeratesFinance Part of Medinet Topco Ltd., Medinet Midco II Ltd. functions as an investment holding British company. The company is based in Sutton Coldfield, UK and was founded in 2016. | Financial Conglomerates | Director/Board Member | |
| Medinet Bidco Ltd. | Miscellaneous | Director/Board Member | |
Medinet Clinical Services Ltd.
 Medinet Clinical Services Ltd. Medical/Nursing ServicesHealth Services Part of Medinet Topco Ltd., Medinet Clinical Services Ltd. is a leading provider of specialised clinical teams delivering additional elective services to the NHS. The company is based in Sutton Coldfield, UK. The British company offers fully managed specialised clinical teams to help reduce NHS waiting times throughout the UK, including urology and general surgery insourcing. The company was founded in 2005 with the intention of easing the pressure on the NHS service, so that it can see and treat more patients. | Medical/Nursing Services | Director/Board Member | |
Pregimmune Corp.
 Pregimmune Corp. Medical/Nursing ServicesHealth Services Pregimmune Corp. is a private company based in Dover, DE. The company specializes in developing novel immunotherapies for pregnancy-related complications. The company's research focuses on understanding the immune system's role in pregnancy and developing therapies to prevent or treat complications such as preeclampsia, preterm birth, and fetal growth restriction. | Medical/Nursing Services | Director/Board Member |
Statistics
International
| Germany | 15 |
| United Kingdom | 13 |
| United States | 13 |
| Bermuda | 4 |
| Switzerland | 3 |
Sectoral
| Consumer Services | 14 |
| Health Technology | 13 |
| Finance | 8 |
| Health Services | 5 |
| Transportation | 4 |
Operational
| Director/Board Member | 29 |
| Corporate Officer/Principal | 12 |
| Chief Tech/Sci/R&D Officer | 7 |
| Doctorate Degree | 6 |
| Chief Executive Officer | 4 |
Most connected contacts
- Stock Market
- Insiders
- Peter Scheurer
- Company connections
